ULCERATIVE COLITIS CHRONIC
Clinical trials for ULCERATIVE COLITIS CHRONIC explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ulcerative colitis: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called eltrekibart, given alone or with another drug (mirikizumab), in 140 adults with moderate-to-severe ulcerative colitis. The goal is to see if the treatment can reduce symptoms and help the colon heal. Participants must have tried other treatments…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hope for kids with IBD: Long-Term drug study launches
Disease control Recruiting nowThis study looks at how well and how safely the drug mirikizumab works over a long period (about 3 years) in children and teenagers with moderate-to-severe ulcerative colitis or Crohn's disease. About 150 participants who have already been in earlier studies will continue treatme…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Could a probiotic ease ulcerative colitis? new study seeks answers
Disease control Recruiting nowThis early-stage study is testing a probiotic called R-3750 in 36 adults with mild to moderate ulcerative colitis. The main goal is to see if the probiotic is safe and well-tolerated. Participants will take the probiotic by mouth and report their symptoms, while researchers check…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC